Navigation Links
Long noncoding RNAs control development of fat cells

CAMBRIDGE, Mass. (February 13, 2013) Whitehead Institute researchers have identified a previously unrecognized layer of genetic regulation that is necessary for the generation of undesirable white fat cells. When this regulation is disrupted, white fat cells are unable to accumulate lipid droplets or mature from their precursors.

"We're trying to figure out what the mechanism iswhat it takes to make fat cells," says Whitehead Founding Member Harvey Lodish, who is also a professor of biology and a professor of bioengineering at MIT. "The obvious reason we're interested in this is because a lot of people have too many of them."

According to the Centers for Disease Control and Prevention, obesityhaving a body mass index (BMI) of 30 or higheris a serious healthcare and economic problem in the United States. More than one-third of American adults are obese, a condition that can lead to heart disease, type 2 diabetes, and stroke. In 2008 obesity-related issues were estimated to cost $147 billion.

All of these problems are caused by an overabundance of white fat cellsadipose tissue cells that store excess energy as fat or lipid droplets. Unlike white fat cells, brown fat cells, which are most prevalent in babies and have a reduced presence in adults, use lipids as fuel to maintain a stable, warm body temperature. Understanding how both types of fat cells are formed and maintained may one day lead to anti-obesity therapies.

In the quest to understand fat-cell generation and maintenance, the Lodish lab scanned mouse fat cells to determine which of the cells' long noncoding RNAs (lncRNAs) are active. Of the 175 identified, 10 lncRNAs were found to play significant roles in these cells.

Residing within what was once dubbed "junk DNA", lncRNAs have recently gained fame as important gene expression regulators that modify chromatin, enhance transcription, and promote messenger RNA (mRNA) degradation, as well as through other methods that have yet to be elucidated. Recently, the Lodish lab identified lncRNAs as playing a vital role in regulating programmed cell death during one of the final stages of red blood cell differentiation.

To determine the function of the identified active lncRNAs in fat cells, Lei Sun, a former postdoctoral researcher in the Lodish lab, and Loyal Goff from Harvard University and the Broad Institute, knocked each lncRNA down individually in fat precursor cells and analyzed the results. When 10 of these lncRNAs had reduced expression, the cells did not turn on the genes that are usually expressed in mature white fat cells, and the cells had significantly smaller lipid droplets than white fat cells with normal lncRNA expression. Their work is reported in this week's issue of the Proceedings of the National Academy of Sciences (PNAS).

"This is the first study showing the importance of lncRNAs for the regulation of adipogeneis," says Sun, who is now an assistant professor at Duke-NUS Graduate Medical School. "Our understanding of lncRNA function in these cells is still incomplete, but in the future, this line of research may reveal new pathways that obesity drugs could target."


Contact: Nicole Rura
Whitehead Institute for Biomedical Research

Related biology news :

1. Advance promises to expand biological control of crop pests
2. Nature Methods study: Using light to control cell clustering
3. Biocontrol research on Brazilian peppertree in Florida discovers new cryptic species
4. Female deer take control during the mating season
5. Dartmouth research offers new control strategies for bipolar bark beetles
6. Chance finding reveals new control on blood vessels in developing brain
7. Scientists discover structure of protein essential for quality control, nerve function
8. Liver controls wasting in cancer
9. Lady beetle diet influences its effectiveness as biocontrol agent
10. New study identifies significance of co-infection in disease control
11. Cruise Control sets runners on right note
Post Your Comments:
(Date:11/2/2015)...  SRI International has been awarded a contract of ... to the National Cancer Institute (NCI) PREVENT Cancer Program ... modern testing and support facilities, and analytical instrumentation to ... studies to evaluate potential cancer prevention drugs. ... Drug Development Program is an NCI-supported pipeline to bring ...
(Date:10/29/2015)... , Oct. 29, 2015  Rubicon Genomics, Inc., ... U.S. distribution of its DNA library preparation products, ... Rubicon,s new ThruPLEX Plasma-seq kit. ThruPLEX Plasma-seq has ... preparation of NGS libraries for liquid biopsies--the analysis ... and prognostic applications in cancer and other conditions. ...
(Date:10/27/2015)... -- In the present market scenario, security is one ... verticals such as banking, healthcare, defense, electronic gadgets, and ... secure & simplified access control and growing rate of ... bank accounts, misuse of users, , and so on. ... and smartphones are expected to provide potential opportunities for ...
Breaking Biology News(10 mins):
(Date:11/30/2015)... , Nov. 30, 2015  AbbVie, is introducing ... that focuses on a daily routine for managing the ... their medication can affect the way the body absorbs ... to their a daily routine are important. The goal ... help patients better manage their hypothyroidism by establishing a ...
(Date:11/30/2015)... and PETACH TIKVAH, Israel , ... BCLI ), a leading developer of adult stem ... subsidiary, Brainstorm Cell Therapeutics Ltd., has been awarded an additional ... Office of the Chief Scientist (OCS). This grant, the second ... for 2015 activities to approximately $1.8 million (approximately NIS7 million).  ...
(Date:11/27/2015)... , November 27, 2015 ... Growing popularity of companion diagnostics is ... cancer biomarkers market with pharmaceutical companies and ... companion diagnostic tests. . ... Complete report on global cancer biomarkers ...
(Date:11/25/2015)... 25, 2015  PharmAthene, Inc. (NYSE MKT: PIP) announced ... stockholder rights plan (Rights Plan) in an effort to ... (NOLs) under Section 382 of the Internal Revenue Code ... PharmAthene,s use of its NOLs could be substantially limited ... in Section 382 of the Code. In general, an ...
Breaking Biology Technology: